We have heard some arguments here today that, if H.R. 3 were to become law, then there is a likelihood that innovation would be driven to China. I think that this is a red herring, let's be clear, because absolutely nothing in H.R. 3 is closing the U.S. market for drug manufacturers or drug development.
Dingell argues against claims that H.R. 3 would harm U.S. drug innovation.
Share
More from Debbie Dingell
The Great Lakes are a shared treasure that generations of Americans and Canadians have worked together to protect.
Republicans are... trying to divide us. And we've got to stop letting them try to divide us.
The quality of care a pregnant woman receives should not depend on the color of her skin, where she lives, or her income.
Other voices in this conversation
